Novo Nordisk the company credited with ushering in the current weight-loss drug revolution when it launched its blockbuster diabetes treatment Ozempic in 2017 is working on its next act, a weight-loss drug called CagriSema
Novo Nordisk lists Ozempic at approximately $968.52 per month, and retail pharmacy costs typically range from about $900 to $1,800 per month
( c ) Body weight time course, ( d ) changes in body weight, fat mass, and fat free mass from day 5 to 26
If youve found a groove that works for you, you want to avoid letting the effects of semaglutide alter things too much
Liraglutide Liraglutide (Victoza, Novo Nordisk) is modified from human GLP-1 (hGLP-1 737) with approximately 97% homology to GLP-1, containing a C16 palmitoyl fatty-acid side-chain at Lys26 and a ser34Arg amino-acid substitution
As always, consult your board-certified clinician to discuss risks, downtime, and anticipated longevity for each possibility